New Stock News | First, Dada Biotech Submits Application to Hong Kong Stock Exchange to Deeply Cultivate the Field of Weight Management.

According to the Securities Times APP, the Hong Kong Stock Exchange disclosed on September 19 that Hangzhou Xianfada Life Science and Technology Co., Ltd.-B (referred to as Xianfada Life Science) has submitted its listing application to the main board of the Hong Kong Stock Exchange. Morgan Stanley, CICC, and CCB International are joint sponsors.